Where does Amicus Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Amicus Therapeutics, Inc. ranks #2,752 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Amicus Therapeutics, Inc. hold?

Amicus Therapeutics, Inc. holds 140 US utility patents granted between 2015 and 2025, spanning 21 technology areas.

What is Amicus Therapeutics, Inc.'s Innovation Score?

Amicus Therapeutics, Inc. has an Innovation Score of 53.4 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Amicus Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Amicus Therapeutics, Inc.'s recent grant velocity is +28% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Amicus Therapeutics, Inc.'s patents?

Amicus Therapeutics, Inc.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Amicus Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Amicus Therapeutics, Inc.

Q: What technology areas does Amicus Therapeutics, Inc. focus on?

Amicus Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 125 patents. Grants appear in 21 CPC subclasses total.

USPTO PatentsView assignee record - 140 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Amicus ranks #2,752 of 49,997 tracked US assignees by granted-patent volume, with 140 patents across 21 technology areas.

#2,752
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.4/100): 19.8
avg claims per patent: +28%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2752 · US Corporation #2,752 · 140 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 140 grants
TOP-DECILE #2,752/49,997
PHOTO-FINISH Ambu A/S
CPC-FOCUS A61K · 21 areas
INNOV-PAR 53.4/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
VEL-UP +28% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ambu A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Amicus Therapeutics · this assignee

53
Brain Tunnelgenix · near

53
Bridgestone Europe / · near

53
JFrog · near

53
Sogang University… · near

53
3D Lighting… · lowest

7

What this shows Amicus's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Amicus's grants concentrate

Amicus Therapeutics, Inc. is a focused PatentsView assignee: 21 CPC subclasses with 89.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (26 grants) versus a trough of 5 in 2021. By volume, Amicus sits between Synaptive Medical Inc. and Chunghwa Picture Tubes, Ltd..

Amicus's three-year grant acceleration

From 2019–2021 to 2022–2024, Amicus Therapeutics, Inc. moved from 40 to 49 grants (1.23x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #749. See the growth leaderboard.

Synaptive Medical

141
Therabody

141
Tomtom Internatio…

141
Ambu A/S

140
Assa Abloy Entran…

140
Bobst MEX

140
Bentley Systems I…

140
Chunghwa Picture…

140
Amicus Therapeuti… ◀

140

What this shows Amicus holds 140 patents at rank #2,752, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Amicus

By rank, the assignees closest to #2,752 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Amicus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amicus, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Sogang University Research Foundation 53 Bridgestone Europe NV/SA 53 JFrog Ltd. 53 Brain Tunnelgenix Technologies Corp. 53

Similar claim depth

Nearest assignees by average claims per patent (19.8 here).

Ixia 19.8 avg Middle Chart, LLC 19.8 avg Empire Technology Development LLC 19.8 avg PlusAI, Inc. 19.8 avg

Amicus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Amicus Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	7.1%
2016	10	7.1%
2017	10	7.1%
2018	13	9.3%
2019	15	10.7%
2020	20	14.3%
2021	5	3.6%
2022	26	18.6%
2023	16	11.4%
2024	7	5.0%
2025partial year	8	5.7%

Which technologies does Amicus Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 125

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 118

C12Y - Enzymes 34

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 30

C07D - Heterocyclic Compounds 24

C07K - Peptides 15

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

Y02A - Technologies FOR Adaptation TO Climate Change 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

H10D - Inorganic Electric Semiconductor Devices 3

H10B - Electronic Memory Devices 3

H01L - Semiconductor Devices NOT Covered BY Class H10 3

C07C - Acyclic OR Carbocyclic Compounds 3

Top 15 of 21 technology areas

Where it ranks

Overall rank by patents

#2,752

of 49,997 tracked assignees

Innovation Score

53.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Amicus Therapeutics, Inc.'s patent record in context - here's where to go next.

Amicus Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 89.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #2,752 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Amicus Therapeutics, Inc. against Synaptive Medical Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.